IACS-13909
IACS-13909 is a selective, potent and orally active SHP2 allosteric inhibitor with an IC50 of 15.7 nM and a Kd of 32 nM. IACS-13909 is more selective for SHP2 than other phosphatases (including SHP1) . IACS-13909 has antitumor activities and suppresses MAPK pathway signaling in receptor tyrosine kinases (RTK) -dependent cancers[1].
Product Specifications
CAS Number
[2160546-07-4]
UNSPSC
12352005
Target
Phosphatase; SHP2
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease; Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/iacs-13909.html
Concentration
10mM
Purity
99.97
Solubility
DMSO : 10 mg/mL (ultrasonic)
Smiles
NC1(C)CCN(C2=CN=C3C(NN=C3C4=CC=CC(Cl)=C4Cl)=N2)CC1
Molecular Formula
C17H18Cl2N6
Molecular Weight
377.27
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
Horseradish Peroxidase Conjugated Goat Affinity Purified Antibody to Human IgG
![Mouse Monoclonal HLA F Antibody (3D11) [DyLight 650]](https://cdn.genprice.uk/genprice/uk/genprice2.webp)
Actin, alpha1, CT (ACTA1, ACTA, Actin, alpha skeletal muscle) (PE) discontinued